Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
JHOP - March 2018 Vol 8, No 1
Original Article
Impact of Pharmacist-Driven Educational Intervention on Documentation of Bowel Function Assessment in Patients with Cancer Who Are Using Opioids
Kimberly N. Flynn, PharmD, BCPS
,
Celestine Gochett, PhD, AOCNS
Read More
Original Article
Microbial Growth of Single-Dose Antineoplastic Drug Vials at 28 Days
Elizabeth R. Pritchard, PharmD, BCOP
,
J. Aubrey Waddell, PharmD, FAPhA, BCOP
,
Brad J. Crane, PharmD, BCPS
,
Amy M. Porter, PharmD
,
Susan Roberts, PharmD
,
Danielle M. Yates, PharmD
,
Angelia M. Thomas, MT (ASCP)
Read More
FDA Updates
The Value of Pre–FDA Approval Healthcare Economic Information Exchange Between Payers and Drug Manufacturers
Peter R. Fendt, PharmD, MBA
,
Brian Ung, PharmD, RPh
,
F. Randy Vogenberg, RPh, PhD
Read More
Case Reports
Aplastic Anemia in a Patient with Anaplastic Oligodendroglioma Postradiation and Concurrent Temozolomide Therapy: Case Report and Review of the Literature
Kirollos S. Hanna, PharmD, BCPS, BCOP
,
Robert Mancini, PharmD, BCOP, FHOPA
,
Matthew Burtelow, MD, PhD
,
Benjamin Bridges, MD
Read More
Symptom Management Overview
Prevention of Thromboembolism in Patients with Multiple Myeloma
Nicole Gerardo, PharmD
Read More
FDA Oncology Update
Recent Cancer Drugs Approved by the FDA
Read More
Phase 2 Study of Brentuximab Vedotin plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma
Read More
Preliminary Results of Prophylactic Tocilizumab After Axicabtagene Ciloleucel (axi-cel; KTE-C19) Treatment for Patients with Relapsed/Refractory, Aggressive NHL
Read More
Median 3.5-Year Follow-Up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle-Cell Lymphoma: A Pooled Analysis
Read More
Adverse Events, Resource Use, and Economic Burden in Patients with Mantle-Cell Lymphoma in the United States
Read More
1
2
Page 1 of 2
Results 1 - 10 of 15